Edifoligide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Edifoligide
Accession Number
DB06556
Type
Biotech
Groups
Investigational
Description
Not Available
Synonyms
  • Edifoligide
External IDs
CGT021
Product Ingredients
IngredientUNIICASInChI Key
Edifoligide sodium8TW510F64S328538-04-1Not applicable
Categories
UNII
4UG613F036
CAS number
476273-48-0

Pharmacology

Indication

Investigated for use/treatment in cardiac surgery, peripheral vascular disease, and kidney disease.

Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1, 2TerminatedDiagnosticChronic Renal Failure (CRF) / Hyperplasia1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on March 19, 2008 10:36 / Updated on June 04, 2019 06:25